Vol.63 No.3 contents

Vol.64

No.1
No.2
No.3
No.4
No.5
No.6
No.7
No.8
No.9
No.10
No.11
No.12
Supplement

Vol.63

Vol.62

Vol.61

Vol.60

Vol.59

Vol.58

Vol.57

No.1
No.2
No.3
No.4
No.5
No.6
No.7
No.8
No.9
No.10
No.11
No.12
Supplement

Vol.56

Vol.55

Vol.54

Vol.53

Vol.52

Vol.51

Vol.50

Vol.49

Vol.48

Vol.47 to 1
(Members Only)

HOME
Rinsho Shinkeigaku (Clinical Neurology)
Vol.63 No.3

Invited Review

Borderline regions between neurology and psychiatry, focusing particularly on the functional neurological disorders

Masahiro Sonoo, M.D.¹⁾

CLINICA NEUROL, 63: 135－144, 2023

Original Article

Antibody production capacity after COVID-19 vaccination in immune-mediated neuromuscular diseases under immunotherapy

Misako Kaido, M.D., Ph.D.¹⁾²⁾, Yuta Kajiyama, M.D., Ph.D.²⁾⁴⁾, Shinya Sasaki, M.T.³⁾, Takako Saitou, M.T.³⁾, Yoshiki Esa, M.D.²⁾, Yushi Watanabe, M.D.²⁾, Harutoshi Fujimura, M.D., Ph.D.²⁾ and Junya Kobayashi, M.D., Ph.D.²⁾

CLINICA NEUROL, 63: 145－151, 2023

Case Report

A case of primary progressive multiple sclerosis with improvement in cognitive impairment by anti-CD20 monoclonal antibody therapy

Hiroyuki Onoue, M.D., Ph.D.¹⁾, Yuta Kato, M.D.¹⁾²⁾, Hideaki Ishido, M.D.¹⁾, Tomohiro Ogawa, M.D., Ph.D.¹⁾, Yasuhisa Akaiwa, M.D., Ph.D.¹⁾ and Tomoyuki Miyamoto, M.D., Ph.D.¹⁾

CLINICA NEUROL, 63: 152－158, 2023